Crossix Co-Founder and CEO Named an Innovator of the Year
DTC Perspectives recognizes Asaf Evenhaim’s contributions to the healthcare marketing industry
NEW YORK, NY – October 9, 2018 – DTC Perspectives, a longstanding pillar in the pharmaceutical marketing space, has named Asaf Evenhaim, CEO and co-founder of Crossix, an Innovator of the Year.
This award was created to honor individuals who strive to improve DTC marketing effectiveness. Honorees were selected based on actual accomplishments that improve the DTC landscape by helping pharmaceutical brands promote their life-saving products to consumers.
Mr. Evenhaim, along with 20 other elite innovators, is being honored tonight during a ceremonial dinner at the 2018 DTC Forum on Social Media & Technology.
For more information about DTC Perspectives’ Innovator Awards, click here. To learn more about Crossix, please contact us at firstname.lastname@example.org.
About Crossix Solutions
Crossix empowers healthcare companies and companies that care about health to plan, measure and optimize their marketing and communication initiatives. Fueled by its Distributed Data Network (DDN) technology and the industry’s most comprehensive set of health and non-health data, which encompasses more than 250 million U.S. consumers, Crossix analytics inform strategic decisions, maximize business results, and drive improved patient outcomes. Crossix connects Rx, OTC, CPG, clinical, medical claims, hospital, consumer and media data with best-in-class privacy safeguards far exceeding HIPAA requirements. Through an unrivaled commitment to innovation and its first-of-their-kind partnerships, Crossix offers an expansive suite of audience and media optimization solutions across programmatic advertising, addressable TV, mobile marketing, search, Point of Care, and beyond. Founded in 2004, Crossix is headquartered in New York City. For more information, visit www.crossix.com.